NCT06756607 The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
| NCT ID | NCT06756607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eastern Cooperative Oncology Group |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-04-25 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2025-04-25 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT research literacy tools in improving Black and Latino patient referral and accrual to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. Also, with the CUSP2CT data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.
Eligibility Criteria
Inclusion Criteria: Participant must be ≥ 18 years of age. Participant must self-identify as Black and/or Latino. Participant must be an oncology patient at a participating NCORP. Participant must be eligible to participate in an ECOG-ACRIN clinical trial. Participant must have the ability to understand and the willingness to sign a e-consent document. Participant must be receiving care at a participating NCORP affiliated community oncology site. Participant must be English or Spanish speaking to be eligible. Participant must have access to a landline, smartphone, computer, or tablet. Exclusion Criteria: \-
Contact & Investigator
Melissa A Simon, MD, MPH
STUDY CHAIR
Eastern Cooperative Oncology Group
Frequently Asked Questions
Who can join the NCT06756607 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06756607 currently recruiting?
Yes, NCT06756607 is actively recruiting participants. Contact the research team at m-simon2@northwestern.edu for enrollment information.
Where is the NCT06756607 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06756607 clinical trial?
NCT06756607 is sponsored by Eastern Cooperative Oncology Group. The principal investigator is Melissa A Simon, MD, MPH at Eastern Cooperative Oncology Group. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.